Bluebird Ventures — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Co-founder and first Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Pam Taub, M.D., FACC(Co-founder)
PartnerJeffrey Bird· solo GP
Co-investorsBroadview VenturesLongitude CapitalAdams Street PartnersARCH Venture PartnersVertex VenturesVertex Ventures HC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.